Pulmonx
Matthew Rettig currently serves as a Quality Engineer III at Pulmonx Corporation, a position held since May 2021. Prior to this role, Matthew Rettig was employed as a Quality Engineer at the same company. From November 2017 to May 2021, Matthew Rettig worked as an Associate Quality Systems Engineer at Outset Medical, Inc. Matthew Rettig earned a Bachelor's degree in Biomedical Engineering from Rensselaer Polytechnic Institute, completing the program in 2017.
This person is not in any teams
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1